SynthesisFrontiers in medicine2026
Exploring IBS in Vietnam: an updated review of current trends and treatment landscape.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with substantial psychosocial and economic impacts. Although research on IBS has expanded in recent years, comprehensive data from low- and middle-income countries, including Vietnam, remain limited. This scoping review provides an updated synthesis of IBS epidemiology, clinical features, diagnostic approaches, treatment strategies, and psychosocial burden in Vietnam. Methods: Following the Arksey and O'Malley framework and Joanna Briggs Institute guidance, we systematically searched PubMed and Google Scholar for studies published between September 2020 and July 2025 in English or Vietnamese. Eligible studies included original research on IBS prevalence, diagnosis, clinical characteristics, and management in Vietnamese populations. Data were extracted and thematically synthesized across four domains: prevalence/epidemiology, clinical and diagnostic features, management strategies, and psychosocial/economic impacts. Results: Twenty-one studies met the inclusion criteria, most being cross-sectional hospital-based investigations. Reported prevalence varied widely, ranging from 5.5% among university students to 68.2% in gastroenterology clinic populations. Rome IV criteria were consistently applied in recent studies. IBS-D and IBS-M emerged as the predominant subtypes, with gender and age influencing distribution. Overlaps with Conclusion: IBS is an increasingly recognized health concern in Vietnam, with high variability in prevalence and strong associations with psychosocial comorbidities. While progress has been made in standardizing diagnostic criteria and initiating interventional studies, critical gaps persist in population-based epidemiology, biomarker validation, pharmacological trials, dietary strategies, and cost-of-illness analyses. Addressing these gaps is essential to optimize IBS care and inform healthcare policy in Vietnam and other resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.